06/10/2026
New research from Yale University is helping uncover what may be driving symptoms in a subset of Long COVID patients.
A recently published study in CELL found evidence that some individuals with Long COVID may develop autoantibodies that mistakenly target their own nervous system and brain tissues, potentially contributing to symptoms such as:
✔ Fatigue
✔ Brain fog
✔ Dizziness
✔ Pain and numbness
✔ Balance issues
✔ Autonomic dysfunction
The findings add to a growing body of evidence linking chronic inflammation, immune dysregulation, and post-viral illness.
At Celly Health, we understand that persistent symptoms often don't fit neatly into a single diagnosis. Our team takes a comprehensive approach to evaluating chronic inflammation, complex chronic illness, and post-infectious conditions, helping patients uncover underlying drivers of their symptoms and develop personalized care plans.
We're also proud to share that Dr. Shawn Cole, Chief Medical Innovation & Strategy Officer at Celly Health, serves as a Faculty Appointment at Yale University School of Medicine, reflecting his ongoing commitment to advancing research, education, and innovation in complex chronic disease management.
As science continues to reveal more about the connections between immune function, inflammation, and chronic illness, our mission remains the same:
Helping patients find answers, restore health, and Celebrate Life Again.
A new study co-led by Yale scientists reveals that antibodies from some long COVID patients attacked brain and nerve tissues, a finding that could point toward treatments.